To obtain access to any datasets listed on this site, you must first receive approval from NIDA Datashare's Data Access Committee (DAC).

Please submit your request by sending your request to NIDA_Datashare_DAC@nih.gov along with the following information:

  • Your name, title, and organization
  • Study Number and Study Title
  • The specific dataset(s) you are requesting
  • The intended use or purpose of the data
  • Willingness to comply with the NIDA Datashare Registration Agreement
Once your request is reviewed, you will receive instructions on how to proceed.

Thank you for your cooperation.

NIDA-CTO-0010

Division
DTMC
HEAL Study
No
Investigator(s)
Thomas F. Newton, M.D.
Title
Assessment of Potential Interactions Between Methamphetamine and Bupropion
Short Description
The purpose of this study is to assess potential interactions between intravenous (IV) methamphetamine and oral bupropion.
Release Date
May 07, 2018
Description

This is a human laboratory clinical pharmacology study to assess potential interactions between IV methamphetamine challenge and treatment with oral sustained-release bupropion.

Keywords
bupropion
interaction
methamphetamine
phase 1b
stimulant
Assessments
Addiction Research Center Inventory
Beck Depression Inventory
Blood Methamphetamine Level
Blood Study Agent Level
Brief Symptom Inventory
ECG Monitoring
Profile of Mood States
Urine Methamphetamine Level
Visual Analog Scales
Vital Signs Monitoring
Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Links
Primary Manuscript
https://www.nature.com/articles/1300979
ClinicalTrials.gov Link
https://clinicaltrials.gov/ct2/show/NCT00040040